Appointment of Stephen M. Deitsch as new Chief Financial Officer OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.

OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners OXFORD, United Kingdom, July 17, 2023 (GLOBE NEWSWIRE) -- OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with...